APA (7th ed.) Citation

Quaak, S., van den Berg, J., Toebes, M., Schumacher, T., Haanen, J., Beijnen, J., & Nuijen, B. (2008). GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial. European Journal of Pharmaceutics & Biopharmaceutics, 70(2), 429. https://doi.org/10.1016/j.ejpb.2008.05.002

Chicago Style (17th ed.) Citation

Quaak, S.G.L, J.H van den Berg, M. Toebes, T.N.M Schumacher, J.B.A.G Haanen, J.H Beijnen, and B. Nuijen. "GMP Production of PDERMATT for Vaccination Against Melanoma in a Phase I Clinical Trial." European Journal of Pharmaceutics & Biopharmaceutics 70, no. 2 (2008): 429. https://doi.org/10.1016/j.ejpb.2008.05.002.

MLA (9th ed.) Citation

Quaak, S.G.L, et al. "GMP Production of PDERMATT for Vaccination Against Melanoma in a Phase I Clinical Trial." European Journal of Pharmaceutics & Biopharmaceutics, vol. 70, no. 2, 2008, p. 429, https://doi.org/10.1016/j.ejpb.2008.05.002.